Abstract: Disclosed herein is a composition comprising a first lanthanide series metal, wherein the composition has a pH of less than 2.0 and is substantially free of peroxide. Also disclosed herein is a composition comprising a first lanthanide series metal and at least one of a second lanthanide series metal, copper, an inorganic phosphate compound, an organophosphate compound, and an organophosphonate compound; wherein the composition is substantially free of peroxide. Also disclosed herein are systems and methods of treating a metal substrate. Also disclosed are substrates treated with the systems and methods.

Abstract: Disclosed herein is a system for treating a magnesium or a magnesium alloy substrate comprising: a first pretreatment composition comprising a fluorometallic acid and free fluoride in an amount of 10 ppm to 500 ppm based on total weight of the first pretreatment composition and having a pH of 1.0 to 4.0; and a second pretreatment composition comprising a lanthanide series metal, the second pretreatment composition being substantially free of peroxide. Also disclosed are methods of treating a magnesium or magnesium alloy substrate. Treated magnesium and magnesium alloy substrates also are disclosed.

Abstract: The present invention relates to compounds of Formula (I), wherein R1, R2, R3, R4 and G are as defined herein. The invention further relates to herbicidal compositions which comprise a compound of Formula (I), to their use for controlling weeds, in particular in crops of useful plants.

Abstract: Disclosed is a sealing composition for treating a metal substrate comprising: a polyolefin component; and a colloidal layered silicate. Also disclosed is a system for treating a metal substrate comprising: a cleaner composition; and/or a pretreatment composition for treating at least a portion of the substrate, the pretreatment composition comprising a Group IVB metal; and a sealing composition for treating at least a portion of the substrate treated with the cleaner composition and/or the pretreated composition, the sealing composition comprising a polyolefin component. Also disclosed is a method of treating a substrate comprising contacting at least a portion of a surface of the substrate with any of the compositions disclosed herein or any of the systems disclosed herein.

Abstract: A non-human organism for upgrading intermediate oxidation products formed by catalytic degradation of alkanes or polystyrenes is provided. The non-human organism is genetically modified to convert the intermediate oxidation products to secondary metabolites, and in particular to include a positive feedback loop construction in the promotor system. A method includes steps of catalytically degrading alkanes or polystyrene in an oxidizing environment to form intermediate products with one or more catalysts and contacting the intermediate products with the non-human organism such that intermediate oxidation products are converted to secondary metabolites.

Abstract: Systems and methods for visual cue based messaging. A visual cue module can provide visual cue data indicative of a visual cue assigned for a contact or a group of contacts from a contact list. A messenger module can output on a display a messenger application GUI. The messenger application GUI includes a message field, a message window with a message thread between a user and the contact or the group of contacts, and a virtual keyboard. The messenger module can output the messenger application GUI with a visual cue graphical element representative of the visual cue to provide a visual indication of the contact or the group of contacts on the display to the user based on the visual cue data. The visual cue can be associated with the messaging field, the message thread, or at least one virtual key of the virtual keyboard.

Abstract: An example medical device includes a container and tube set arranged and configured to couple to an endoscope, a first gas supply, and a second gas supply for use in an endoscopic procedure. The container and tube set includes a container having an interior volume configured to contain a fluid, a gas supply tube having a first end and a second end in fluid communication with the interior volume of the container, and a coupling mechanism having a first end and a second end, wherein the first end of the coupling mechanism is configured to engage with the second end of the gas supply tube and the second end of the coupling mechanism is configured to engage with both the first gas supply and the second gas supply interchangeably.

Abstract: Devices, systems, and methods for mitigating leakage from connectors and tubing of an endoscope system when the connectors and or tubing are disconnected from fluid ports of the endoscope system. A tubing assembly for connecting a fluid line to an endoscope and a fluid source may include an elongate tube having a lumen, a connector coupled to an end of the elongate tube and having a port in fluid communication with the lumen, and a fluid control component configured to selective adjust fluid flow through the lumen and the port. The fluid control component may be located in one or more of a cover for the fluid source, the tubing, the connector, and/or other components in fluid communication with the lumen. The fluid control component may be a valve. The valve may be manually actuated from a closed position to an opened position.

Abstract: Embodiments of the present invention disclose a method, computer program product, and system for repurchasing a product. A method comprising receiving motion data from a wearable device and determining an activity that corresponds to the motion data. Increasing a counter for the activity every time the activity occurs and determining if the counter is greater than or equal to a threshold value that is associated with a product used during the activity. Transmitting a repurchase order of the product associated with the activity when the counter is greater than or equal to the threshold value.

Abstract: A breath test and a breath test method for diagnosing abnormal gastric emptying using a 13C labeled breath test meal by identifying the time of maximum excretion of 13CO2 in the breath samples. The test and test method include supplying a subject with the breath test meal, collecting a breath sample of the subject at a plurality of time points after the subject consumes the meal, generating measurements of 13CO2 excretion from the breath samples, identifying a time Tmax at which 13CO2 excretion is maximal, comparing Tmax to a cut-off value. The subject may be diagnosed as having delayed gastric emptying if Tmax is greater than the Tmax cut-off value.

Abstract: The invention concerns compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R1 to R5 have any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.

Abstract: Automated detection of pipeline ruptures using machine learning techniques. A plurality of independent rupture detection techniques each generate a status determination indicative of whether the pipeline is ruptured. A combiner utilizing a neural network algorithm analyzes the status determinations to generate a single, high-confidence status determination indicative of whether the pipeline is ruptured.

Abstract: The invention concerns compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R1 to R5 have any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.

Abstract: The invention provides a field device configured to be fitted through a single mounting aperture in a vessel. The device preferably includes a vibrating fork and a temperature sensor, the signals from which are processed within the device to provide an output indicative of whether a property of a medium in contact with the device is above or below a threshold. This output may be communicated wirelessly to a remote location. Other features are described.

Abstract: The present invention relates to an electrical assembly which has a conformal coating, wherein said conformal coating is obtainable by a method which comprises: (a) plasma polymerization of a compound of formula (I) and a fluorohydrocarbon, wherein the molar ratio of the compound of formula (I) to the fluorohydrocarbon is from 5:95 to 50:50, and deposition of the resulting polymer onto at least one surface of the electrical assembly: wherein: R1 represents C1-C3 alkyl or C2-C3 alkenyl; R2 represents hydrogen, C1-C3 alkyl or C2-C3 alkenyl; R3 represents hydrogen, C1-C3 alkyl or C2-C3 alkenyl; R4 represents hydrogen, C1-C3 alkyl or C2-C3 alkenyl; R5 represents hydrogen, C1-C3 alkyl or C2-C3 alkenyl; and R6 represents hydrogen, C1-C3 alkyl or C2-C3 alkenyl, and (b) plasma polymerization of a compound of formula (I) and deposition of the resulting polymer onto the polymer formed in step (a).

Abstract: Fiber optic cable demarcations inhibiting movements of optical fibers relative to strength members, and related cable assemblies and methods, are disclosed. By bonding optical fibers to strength members with a bonding agent received into at least one cavity, a demarcation may be formed inside the cable jacket at a cable jacket interface. The at least one cavity may be disposed within a cable jacket of a fiber optic cable and at the cable jacket interface. The demarcation may bond at least one optical fiber and at least one strength member together to inhibit longitudinal movement of the at least one optical fiber relative to the at least one strength member. In this manner, the demarcation may inhibit optical fiber movement within the fiber optic connector, which may cause tensile forces and/or buckling of the optical fiber resulting in optical fiber damage and/or optical attenuation.

Abstract: Fiber optic cable demarcations inhibiting movements of optical fibers relative to strength members, and related cable assemblies and methods, are disclosed. By bonding optical fibers to strength members with a bonding agent received into at least one cavity, a demarcation may be formed inside the cable jacket at a cable jacket interface. The at least one cavity may be disposed within a cable jacket of a fiber optic cable and at the cable jacket interface. The demarcation may bond at least one optical fiber and at least one strength member together to inhibit longitudinal movement of the at least one optical fiber relative to the at least one strength member. In this manner, the demarcation may inhibit optical fiber movement within the fiber optic connector, which may cause tensile forces and/or buckling of the optical fiber resulting in optical fiber damage and/or optical attenuation.

Abstract: The invention concerns compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R1 to R5 have any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.

Abstract: Fiber optic cable demarcations inhibiting movements of optical fibers relative to strength members, and related cable assemblies and methods, are disclosed. By bonding optical fibers to strength members with a bonding agent received into at least one cavity, a demarcation may be formed inside the cable jacket at a cable jacket interface. The at least one cavity may be disposed within a cable jacket of a fiber optic cable and at the cable jacket interface. The demarcation may bond at least one optical fiber and at least one strength member together to inhibit longitudinal movement of the at least one optical fiber relative to the at least one strength member. In this manner, the demarcation may inhibit optical fiber movement within the fiber optic connector, which may cause tensile forces and/or buckling of the optical fiber resulting in optical fiber damage and/or optical attenuation.

Abstract: The present invention relates to an electrical assembly which has a conformal coating, wherein said conformal coating is obtainable by a method which comprises: (a) plasma polymerization of a compound of formula (I) and a fluorohydrocarbon, wherein the molar ratio of the compound of formula (I) to the fluorohydrocarbon is from 5:95 to 50:50, and deposition of the resulting polymer onto at least one surface of the electrical assembly: wherein: R1 represents C1-C3 alkyl or C2-C3 alkenyl; R2 represents hydrogen, C1-C3 alkyl or C2-C3 alkenyl; R3 represents hydrogen, C1-C3 alkyl or C2-C3 alkenyl; R4 represents hydrogen, C1-C3 alkyl or C2-C3 alkenyl; R5 represents hydrogen, C1-C3 alkyl or C2-C3 alkenyl; and R6 represents hydrogen, C1-C3 alkyl or C2-C3 alkenyl, and (b) plasma polymerization of a compound of formula (I) and deposition of the resulting polymer onto the polymer formed in step (a).